Dementia: timely diagnosis and early intervention

#### The bottom line Dementia describes a clinical syndrome that encompasses difficulties in memory, language, and behaviour that leads to impairments in activities of daily living. Alzheimer’s disease is the most common subtype of dementia, followed by vascular dementia, mixed dementia, and dementia with Lewy bodies. Because the global population is rapidly ageing, dementia has become a concern worldwide1; the illness places considerable burden on individuals and their families and also on health and social care provision. #### Sources and selection criteria We searched for articles through Medline, PubMed, and the Cochrane database of systematic reviews from January 2006 to December 2014—the period after publication of the current UK national dementia guidance9—using the search terms “dementia”, “Alzheimer’s”, “carer”, and “caregiver”. Additional searches were carried out for specific subsections—for example, “pharmacologic treatment” and “non-pharmacologic interventions/strategies/treatment”. Where possible, we focused on systematic reviews, meta-analyses, and high quality randomised controlled trials. We included only articles in English and excluded those published in non-peer reviewed journals. Recommendations in this review are derived from the most recent international and UK national …

[1]  Alan J. Thomas,et al.  Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study. , 2015, The British journal of psychiatry : the journal of mental science.

[2]  R. Bullock,et al.  Validation of a 6 item cognitive impairment test with a view to primary care usage , 1999, International journal of geriatric psychiatry.

[3]  Henry Brodaty,et al.  Meta‐Analysis of Psychosocial Interventions for Caregivers of People with Dementia , 2003, Journal of the American Geriatrics Society.

[4]  S. Borson,et al.  The Mini‐Cog: a cognitive ‘vital signs’ measure for dementia screening in multi‐lingual elderly , 2000, International journal of geriatric psychiatry.

[5]  L. Robinson,et al.  A systematic review of the effectiveness of advance care planning interventions for people with cognitive impairment and dementia. , 2012, Age and ageing.

[6]  J. Steen Dying with dementia: what we know after more than a decade of research. , 2010 .

[7]  Assessing and helping carers of older people , 2011, BMJ : British Medical Journal.

[8]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[9]  M. O. Olde Rikkert,et al.  Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial , 2012, BMJ : British Medical Journal.

[10]  John R Hodges,et al.  The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.

[11]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[12]  Martin Knapp,et al.  Donepezil and memantine for moderate-to-severe Alzheimer's disease. , 2012, The New England journal of medicine.

[13]  Nick C Fox,et al.  The diagnosis of young-onset dementia , 2010, The Lancet Neurology.

[14]  Gary W. Pritchard,et al.  The provision of assistive technology products and services for people with dementia in the United Kingdom , 2016, Dementia.

[15]  Martin Prince,et al.  World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors , 2014 .

[16]  Peter Cudd,et al.  Assistive technology for people with dementia , 2014 .

[17]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[18]  J. Yokomizo,et al.  Cognitive screening for dementia in primary care: a systematic review , 2014, International Psychogeriatrics.

[19]  W F Stewart,et al.  Screening for dementia with the Memory Impairment Screen , 1999, Neurology.

[20]  Craig Ritchie,et al.  Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.

[21]  H. Brodaty,et al.  The GPCOG: A New Screening Test for Dementia Designed for General Practice , 2002, Journal of the American Geriatrics Society.

[22]  S. Iliffe,et al.  Primary care and dementia: 1. diagnosis, screening and disclosure , 2009, International journal of geriatric psychiatry.

[23]  O. Ukoumunne,et al.  ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.

[24]  J. T. van der Steen Dying with dementia: what we know after more than a decade of research. , 2010, Journal of Alzheimer's disease : JAD.

[25]  M. Eccles,et al.  Can primary care record review facilitate earlier diagnosis of dementia? , 2007, Family practice.

[26]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[27]  M. Prince,et al.  World Alzheimer Report 2013 , 2014 .

[28]  L. Schneider,et al.  Lack of evidence for the efficacy of memantine in mild Alzheimer disease. , 2011, Archives of neurology.

[29]  K. Shulman Clock‐drawing: is it the ideal cognitive screening test? , 2000, International journal of geriatric psychiatry.

[30]  A. Mitchell,et al.  A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia , 2013, International Psychogeriatrics.

[31]  K. Davis Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[32]  J. Bond,et al.  The transition to dementia – individual and family experiences of receiving a diagnosis: a review , 2011, International Psychogeriatrics.

[33]  M. Knapp,et al.  Dementia care costs and outcomes: a systematic review , 2013, International journal of geriatric psychiatry.

[34]  J T O'Brien,et al.  EFNS guidelines for the diagnosis and management of Alzheimer’s disease , 2010, European journal of neurology.

[35]  Yemisi Takwoingi,et al.  (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.

[36]  A. Milne,et al.  Screening for dementia in primary care: a review of the use, efficacy and quality of measures , 2008, International Psychogeriatrics.

[37]  S. Iliffe,et al.  Primary care and dementia: 2. long‐term care at home: psychosocial interventions, information provision, carer support and case management , 2001, International journal of geriatric psychiatry.

[38]  O. Kostopoulou,et al.  Diagnostic difficulty and error in primary care--a systematic review. , 2008, Family practice.

[39]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[40]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.